Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation

Clinical trial NCT00642655 · COMPLETED

Trial details

NCT number: NCT00642655
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Kidney Transplant

Start date: 2005-09-01
Primary completion: 2007-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.